Shocking Decisions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shocking Decisions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shocking Decisions Today - Breaking & Trending Today

Study Confirming Overwhelming Reduction in Bleeding of the Dual-Acting Factor XI/XIa Inhibitor Abelacimab as Compared to Rivaroxaban Selected as Late-Breaker Oral Presentation at the American Heart Association Scientific Sessions

Published: September 26, 2023

Study participants may transition from the rivaroxaban arm to abelacimab in an extension study 

Source: dicardiology.com

Related Topics:

United StatesJohn GlasspoolStudy GroupData Monitoring CommitteeBroad InstituteDrug AdministrationAmerican Heart Association Scientific SessionsBlackstone Life SciencesHarvard Medical SchoolAnthos Therapeutics IncPennsylvania Convention CenterAnthos TherapeuticsLate BreakingPrincipal Investigator ChristianGeneral CardiologySenior InvestigatorAssociate MemberAssociate ProfessorHarvard MedicalBreaker Presentation DetailsNovel FactorAtrial FibrillationPrimary ResultsLate Breaking ScienceShocking Decisions